News | June 23, 2026
FDA advisory panel backs Moderna flu vaccine candidate for older adults
The backing comes as influenza remains a persistent public health burden
The backing comes as influenza remains a persistent public health burden
The company said the safety profile remained consistent with earlier studies and was considered manageable
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
Clearing 19 biologics for Europe market
The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows
About 250+ women riders participate in the awareness ride where free breast screening camp were conducted
Subscribe To Our Newsletter & Stay Updated
